Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).

Roberto A Leon-FerrePaul J NovotnyEric G WolfeStephanie S FaubionKathryn J RuddyDaniel FloraChristopher S R DakhilKendrith M RowlandMark L GrahamNguyet Le-LindqwisterThomas J SmithCharles L Loprinzi

Published in: JNCI cancer spectrum (2019)

Oxybutynin is an effective and relatively well-tolerated treatment option for women with HFs.

Keyphrases

double blind
clinical trial
placebo controlled
phase iii
phase ii
study protocol
open label
randomized controlled trial
replacement therapy
young adults